Sleep disorders in women: why insomnia hits harder and what the data shows

A woman I counsel on nutrition recently told me she could not remember the last time she slept through the night. She is 47, perimenopausal, and wakes up drenched in sweat at 3 a.m. most nights. Her doctor told her this was "normal for her age." It may be common. Normal is a different question.

Sleep disorders affect women at significantly higher rates than men across nearly every diagnostic category. Insomnia, the most prevalent sleep disorder, is 40% more common in women. The reasons are not mysterious (they are hormonal, physiological, and social) but they remain undertreated because the medical establishment has historically studied sleep in male subjects and applied those findings to everyone.

This article covers what the data tells us about sleep disorders in women: who is affected, when the risk peaks, why sleep apnea gets missed, and what evidence-based approaches actually work.

How common are sleep disorders in women

Sleep complaints are among the most common health concerns women raise with their doctors. The National Sleep Foundation's 2024 Sleep in America Poll found that 67% of women reported experiencing at least one symptom of a sleep disorder (difficulty falling asleep, staying asleep, or waking up feeling unrefreshed) compared to 54% of men.

The gender gap in insomnia specifically has been documented in a well-cited meta-analysis by Zhang and Wing, published in Sleep in 2006, which pooled data from 29 studies and found that women had a 41% higher risk of insomnia compared to men. That gap is not a relic of older data. Subsequent studies, including a 2019 analysis of 13,000 adults published in The Lancet Psychiatry, confirmed that the sex difference persists even after controlling for depression and anxiety.

Chronic insomnia (defined as difficulty sleeping at least three nights per week for three months or longer) affects an estimated 10% to 15% of the adult population. Among women over 45, the rate climbs to 20% to 25%. Among women in the perimenopausal transition, it reaches 35% to 60%, depending on how strictly "sleep disturbance" is defined.

Beyond insomnia, women are also more likely to experience restless legs syndrome (about 1.5 to 2 times more common in women) and circadian rhythm disruptions related to shift work. The one major sleep disorder where men predominate (obstructive sleep apnea) turns out to be significantly underdiagnosed in women, as we will discuss below.

The hormonal connection

The sex difference in sleep disorders tracks hormonal milestones with striking consistency. Before puberty, boys and girls have roughly equal rates of insomnia. The gap opens at menarche and widens at each subsequent hormonal transition: the menstrual cycle, pregnancy, postpartum, perimenopause, and menopause.

Estrogen and progesterone both influence sleep architecture. Progesterone has a sedative effect — it acts on GABA receptors, the same targets as benzodiazepines. When progesterone levels drop in the late luteal phase of the menstrual cycle, sleep quality worsens. About 30% of women report poorer sleep in the days leading up to menstruation, and women with premenstrual dysphoric disorder (PMDD) have measurably worse sleep quality during the late luteal phase on polysomnography.

Estrogen influences thermoregulation, serotonin metabolism, and REM sleep. When estrogen levels fluctuate (as they do dramatically during perimenopause) the effects on sleep are physiological, not psychological. Hot flashes, which affect 75% to 85% of menopausal women, directly fragment sleep. A hot flash typically raises core body temperature by 0.5 to 1°C, triggers a sweat response, and produces an arousal from sleep that takes 10 to 30 minutes to recover from. Women who experience frequent hot flashes lose an estimated 30 to 60 minutes of sleep per night.

If you experience sleep changes that correlate with your cycle, tracking the pattern can be informative for your clinician. Our period calculator and cycle length calculator can help you map symptom patterns against cycle phases.

Insomnia across the reproductive lifespan

Sleep problems in women are not static. They shift with reproductive stage in ways that have specific clinical implications.

Menstrual cycle. About 30% of women report worse sleep in the premenstrual phase. Polysomnographic studies show increased sleep onset latency and more nighttime awakenings during the late luteal phase. Women with PMDD or severe PMS have the most pronounced effects. The mechanism is likely the sharp progesterone withdrawal that occurs in the days before menstruation.

Pregnancy. Sleep disturbance during pregnancy is nearly universal. The National Sleep Foundation reported that 78% of pregnant women experience sleep problems, with prevalence highest in the third trimester. First trimester sleep disruption is primarily driven by nausea, urinary frequency, and progesterone-induced drowsiness that paradoxically fragments nighttime sleep. Third trimester issues include physical discomfort, fetal movement, frequent urination, and a sharp increase in snoring and sleep-disordered breathing. About 25% to 30% of pregnant women develop habitual snoring by the third trimester, up from about 4% pre-pregnancy.

Postpartum. The postpartum period produces the most severe sleep deprivation most women will ever experience, driven primarily by infant feeding demands. In the first three months postpartum, mothers average 6.5 to 7 hours of total sleep per 24-hour period, but that sleep is fragmented into segments of 2 to 3 hours. Fragmented sleep, even when the total hours are technically adequate, fails to provide the restorative deep sleep and REM stages the brain requires. The link between postpartum sleep deprivation and postpartum depression is well established — and bidirectional. Poor sleep worsens mood, and depression worsens sleep.

Perimenopause and menopause. This is where the data is most dramatic, and it warrants its own section.

Sleep apnea: the overlooked diagnosis

Obstructive sleep apnea (OSA) has historically been considered a disease of overweight men who snore loudly. That clinical picture is accurate for one demographic and misleading for another.

Population studies estimate that sleep apnea affects about 9% to 15% of women, compared to 24% to 30% of men. But the diagnostic rate in women is dramatically lower. A landmark study by Young et al. published in the New England Journal of Medicine found that 93% of women with moderate-to-severe sleep apnea had not been diagnosed. The comparable figure for men was 82%. Women with sleep apnea are 2 to 3 times less likely to receive a diagnosis than men with equivalent disease severity.

The problem is presentation. Women with sleep apnea are less likely to present with classic loud snoring and witnessed apneas — the symptoms that trigger referral for a sleep study. Instead, women more often report insomnia, fatigue, morning headaches, mood disturbance, and difficulty concentrating. These symptoms get attributed to depression, anxiety, menopause, or "stress" rather than to an obstructed airway.

Women also tend to have sleep apnea that occurs preferentially during REM sleep, which means their overall apnea-hypopnea index (AHI) may appear normal on a full-night study even when REM-specific AHI is severely elevated. Clinicians who rely on overall AHI alone can miss the diagnosis.

Untreated sleep apnea increases the risk of hypertension, type 2 diabetes, atrial fibrillation, stroke, and cardiovascular mortality. In women, untreated OSA has also been associated with pregnancy complications, including gestational hypertension and preeclampsia. The rising prevalence of obesity in women of reproductive age is increasing sleep apnea risk in a population that is rarely screened for it.

If you have been told you have "just insomnia" but you also experience daytime fatigue, morning headaches, or unrefreshing sleep despite adequate hours in bed, ask your doctor specifically about a sleep apnea evaluation. The condition is treatable, and the cardiovascular benefits of treatment are well documented.

Menopause and the sleep cliff

The SWAN study (the Study of Women's Health Across the Nation) is the largest longitudinal study of the menopausal transition, tracking over 3,300 women across multiple racial and ethnic groups since 1994. Its sleep data is some of the most detailed we have.

SWAN found that 35% to 40% of women in early perimenopause reported frequent sleep difficulty. By late perimenopause, the figure rose to 45% to 50%. Among postmenopausal women, sleep complaints stabilized but remained elevated compared to premenopausal levels. The research team, led by Howard Kravitz at Rush University, published findings showing that sleep difficulty increased linearly across the menopausal transition, even after adjusting for hot flashes, depression, and demographic factors.

Hot flashes are the most obvious disruptor. A 2018 review by Baker et al., published in Nature and Science of Sleep, found that women with moderate-to-severe hot flashes had objectively worse sleep efficiency, more nighttime awakenings, and less time in slow-wave (deep) sleep compared to women without vasomotor symptoms. The relationship was dose-dependent: more frequent hot flashes meant worse sleep.

But hot flashes do not explain all of it. SWAN data showed that even women who did not report hot flashes experienced an increase in sleep difficulty during the menopausal transition. The hormonal changes themselves (declining estrogen, fluctuating progesterone, altered melatonin production) appear to affect sleep regulation directly, independent of vasomotor symptoms.

The mood connection also matters. Women are twice as likely to develop depression during the menopausal transition as they are in the years before or after. Sleep disturbance and depression during perimenopause share a bidirectional relationship that can create a self-reinforcing cycle. For a more complete picture of the perimenopausal experience, our perimenopause guide covers the full range of symptoms.

What poor sleep does to women's health

Sleep deprivation is not just an inconvenience. It has measurable effects on nearly every organ system, and several of these effects are sex-specific or sex-amplified.

Cardiovascular risk. A 2019 study published in Journal of the American Heart Association found that women who slept fewer than 6 hours per night had a 20% to 30% higher risk of cardiovascular disease compared to those sleeping 7 to 8 hours. The association was stronger in women than in men, even after adjusting for traditional risk factors. Short sleep duration increases blood pressure, promotes systemic inflammation, and impairs glucose metabolism — a combination that accelerates atherosclerosis.

Weight and metabolism. Sleep restriction alters hunger hormones. Leptin (which signals satiety) decreases and ghrelin (which signals hunger) increases with insufficient sleep. A controlled study at the University of Chicago found that participants restricted to 4 hours of sleep per night consumed an average of 300 additional calories per day, with a preference for high-carbohydrate, high-fat foods. Chronic short sleep is associated with a 30% to 50% higher risk of obesity.

Mental health. Insomnia is both a symptom and a risk factor for depression. Women with chronic insomnia are 2 to 3 times more likely to develop major depressive disorder. The relationship runs both directions: treating insomnia with cognitive behavioral therapy (CBT-I) has been shown to reduce depressive symptoms even when depression is not directly targeted.

Immune function. Sleep deprivation impairs the production of cytokines and reduces the effectiveness of vaccines. Women with autoimmune conditions frequently report that poor sleep triggers disease flares. Our article on autoimmune disease in women covers the intersection of immune dysregulation and hormonal factors in more detail.

Reproductive outcomes. Short sleep duration during pregnancy is associated with longer labor, higher rates of cesarean delivery, and increased risk of gestational diabetes and preeclampsia. In non-pregnant women, chronic sleep deprivation has been linked to irregular menstrual cycles and impaired fertility, though the evidence is weaker than for the cardiovascular and metabolic effects.

The economic cost of sleep deprivation

The RAND Corporation published the most detailed economic analysis of insufficient sleep in 2016, and the numbers are large enough to reframe sleep as a public health priority rather than a lifestyle preference.

RAND estimated that insufficient sleep costs the U.S. economy up to $411 billion per year, equivalent to about 2.28% of GDP. The primary driver is lost productivity: workers sleeping fewer than 6 hours per night lose roughly 6 additional working days per year compared to those sleeping 7 to 9 hours, through absenteeism, presenteeism (showing up but underperforming), and workplace accidents.

Japan, the UK, Germany, and Canada showed similar patterns scaled to their economies. The U.S. figure was the largest in absolute terms and among the highest per capita.

For women specifically, the economic burden of sleep loss is compounded by the caregiving expectations that drive much of it. Women are more likely than men to be primary nighttime caregivers for infants, children with sleep disorders, and aging parents. A 2022 American Time Use Survey analysis found that among parents of children under 6, mothers averaged 45 minutes less sleep per night than fathers. That gap persisted even in dual-income households.

Healthcare utilization also rises with poor sleep. Women with insomnia have healthcare costs approximately 60% higher than women without sleep disorders, driven by increased primary care visits, mental health treatment, and prescription medication use.

What actually helps

The evidence on sleep interventions is clearer than most people expect. Some treatments work. Some are overhyped. Here is what the data supports.

Cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment recommended by the American Academy of Sleep Medicine, the American College of Physicians, and the European Sleep Research Society. It works better than medication for chronic insomnia and produces effects that last after treatment ends. CBT-I typically involves 6 to 8 sessions and includes sleep restriction therapy, stimulus control, cognitive restructuring, and sleep hygiene education. Meta-analyses show it reduces sleep onset latency by an average of 19 minutes and wakefulness after sleep onset by 26 minutes. Digital CBT-I programs (like Insomnia Coach and SHUTi) have shown comparable efficacy for mild to moderate insomnia.

Hormone therapy for menopausal sleep disturbance. For women whose sleep disruption is driven by hot flashes, systemic estrogen therapy is the most effective treatment. A Cochrane review found that hormone therapy reduced hot flash frequency by 75% and significantly improved subjective and objective sleep quality. The decision to use hormone therapy involves a risk-benefit assessment that accounts for cardiovascular risk, breast cancer risk, and symptom severity. It is not appropriate for everyone, but for women with severe vasomotor symptoms and sleep disruption, it can be transformative.

Melatonin. Exogenous melatonin has modest evidence for advancing circadian timing and reducing sleep onset latency. It is most useful for circadian rhythm disorders and jet lag, with less consistent benefit for primary insomnia. Doses of 0.5 to 3 mg taken 1 to 2 hours before desired bedtime are typical. Higher doses are not more effective and can cause morning grogginess. Melatonin production declines with age, which is why some clinicians recommend it for older women, though the evidence is not definitive.

Exercise. Regular aerobic exercise improves sleep quality by a magnitude comparable to many pharmacological treatments. A meta-analysis of 29 studies found that exercise reduced sleep onset latency by 10 minutes, increased total sleep time by 10 minutes, and improved sleep efficiency. The effects are strongest with moderate-intensity exercise performed regularly, not occasionally. The timing matters less than the consistency, though exercising within 1 to 2 hours of bedtime can be stimulating for some people.

Sleep hygiene alone is not enough. Consistent sleep schedules, a cool dark bedroom, limiting caffeine after noon, and avoiding screens before bed are all reasonable practices. But for women with clinical insomnia, sleep hygiene education without CBT-I has not been shown to produce meaningful improvement. Telling someone with chronic insomnia to "practice better sleep hygiene" is the equivalent of telling someone with depression to "think positive." It is technically not wrong, but it is insufficient.

Frequently asked questions about women and sleep disorders

Why do women have more insomnia than men?

Women are 40% more likely to develop insomnia than men, per a meta-analysis published in Sleep. The gap is driven by hormonal fluctuations across the reproductive lifespan — progesterone withdrawal before menstruation, sleep disruption during pregnancy, and estrogen decline during menopause all fragment sleep. Social factors, including disproportionate caregiving responsibilities, also contribute. The sex difference emerges at puberty and widens with age.

How common are sleep problems during menopause?

Very common. Data from the SWAN study found that 35% to 60% of perimenopausal and postmenopausal women report significant sleep disturbances. Hot flashes, which affect 75% to 85% of menopausal women, directly fragment sleep by causing nighttime awakenings. Even women without hot flashes experience increased sleep difficulty during the menopausal transition, suggesting that hormonal changes affect sleep regulation independently.

Is sleep apnea underdiagnosed in women?

Yes, significantly. Women with sleep apnea are 2 to 3 times less likely to be diagnosed than men with equivalent disease severity. The reason is that women tend to present with atypical symptoms (insomnia, fatigue, depression, and morning headaches) rather than the loud snoring that triggers referral for sleep studies. A study published in the New England Journal of Medicine found that 93% of women with moderate-to-severe sleep apnea had not been diagnosed.

What is the best treatment for insomnia?

Cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment recommended by the American Academy of Sleep Medicine and the American College of Physicians. It is more effective than medication for chronic insomnia and produces lasting results after treatment ends. CBT-I typically involves 6 to 8 sessions covering sleep restriction, stimulus control, and cognitive restructuring. For menopausal women, treating the underlying hot flashes with hormone therapy can significantly improve sleep quality.

Does poor sleep affect heart health in women?

Yes. A 2019 study in the Journal of the American Heart Association found that women sleeping fewer than 6 hours per night had a 20% to 30% higher risk of cardiovascular disease. The association was stronger in women than in men. Short sleep raises blood pressure, promotes inflammation, and impairs glucose metabolism. Untreated sleep apnea further increases cardiovascular risk, including hypertension, atrial fibrillation, and stroke.

How much does poor sleep cost the economy?

The RAND Corporation estimated that insufficient sleep costs the U.S. economy up to $411 billion annually, equivalent to about 2.28% of GDP and 1.2 million lost working days. Workers sleeping fewer than 6 hours per night lose roughly 6 additional working days per year compared to those sleeping 7 to 9 hours. Women with insomnia have healthcare costs approximately 60% higher than women without sleep disorders.